Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · Real-Time Price · USD
1.350
-0.040 (-2.88%)
At close: Apr 1, 2025, 4:00 PM
1.330
-0.020 (-1.48%)
After-hours: Apr 1, 2025, 7:00 PM EDT

Akoya Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Cash & Equivalents
11.7883.1374.23113.0817.01
Upgrade
Short-Term Investments
23.26-6.99--
Upgrade
Cash & Short-Term Investments
35.0483.1381.22113.0817.01
Upgrade
Cash Growth
-57.85%2.35%-28.18%564.94%-21.48%
Upgrade
Accounts Receivable
13.7816.999.739.446.47
Upgrade
Other Receivables
---5.09-
Upgrade
Receivables
13.7816.999.7314.546.47
Upgrade
Inventory
24.3217.8814.499.014.26
Upgrade
Prepaid Expenses
3.263.796.764.180.96
Upgrade
Other Current Assets
0.33----
Upgrade
Total Current Assets
76.73121.79112.2140.8128.7
Upgrade
Property, Plant & Equipment
12.9820.6622.457.495.53
Upgrade
Goodwill
18.2618.2618.2618.2618.26
Upgrade
Other Intangible Assets
14.5617.4120.0521.1522.71
Upgrade
Long-Term Deferred Tax Assets
0.130.040.04--
Upgrade
Long-Term Deferred Charges
-0.330.33-0.27
Upgrade
Other Long-Term Assets
2.341.882.713.192.19
Upgrade
Total Assets
125.01180.37176.03190.9177.66
Upgrade
Accounts Payable
8.7611.7810.639.445.07
Upgrade
Accrued Expenses
8.510.4311.1612.285.43
Upgrade
Current Portion of Long-Term Debt
----1.03
Upgrade
Current Portion of Leases
3.283.453.630.270.2
Upgrade
Current Unearned Revenue
6.556.696.284.483.84
Upgrade
Other Current Liabilities
2.353.015.361.211.59
Upgrade
Total Current Liabilities
29.4435.3537.0627.6817.16
Upgrade
Long-Term Debt
76.1875.2563.2832.4733.49
Upgrade
Long-Term Leases
4.6878.880.20.28
Upgrade
Long-Term Unearned Revenue
3.063.192.111.331.01
Upgrade
Long-Term Deferred Tax Liabilities
0.130.040.090.030.17
Upgrade
Other Long-Term Liabilities
3.915.776.047.857.47
Upgrade
Total Liabilities
117.41126.6117.4569.5659.58
Upgrade
Common Stock
00000
Upgrade
Additional Paid-In Capital
293.02283.84225.33217.46-
Upgrade
Retained Earnings
-285.44-230.07-166.75-96.11-52.28
Upgrade
Comprehensive Income & Other
0.01--0.01--
Upgrade
Total Common Equity
7.653.7758.58121.35-52.28
Upgrade
Shareholders' Equity
7.653.7758.58121.3518.08
Upgrade
Total Liabilities & Equity
125.01180.37176.03190.9177.66
Upgrade
Total Debt
84.1585.7175.7832.9434.99
Upgrade
Net Cash (Debt)
-49.11-2.585.4380.14-17.99
Upgrade
Net Cash Growth
---93.22%--
Upgrade
Net Cash Per Share
-0.99-0.060.142.98-7.59
Upgrade
Filing Date Shares Outstanding
49.8249.1438.3437.482.56
Upgrade
Total Common Shares Outstanding
49.5749.1238.2937.422.56
Upgrade
Working Capital
47.2986.4575.14113.1311.53
Upgrade
Book Value Per Share
0.151.091.533.24-20.39
Upgrade
Tangible Book Value
-25.2318.120.2781.94-93.26
Upgrade
Tangible Book Value Per Share
-0.510.370.532.19-36.37
Upgrade
Machinery
13.3114.5212.529.986.53
Upgrade
Leasehold Improvements
5.255.883.981.571.26
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q